Target intelligence / Profile preview

RNA-directed RNA polymerase L (Respiratory syncytial virus) (RSV L protein)

Target
RSV L protein
Molecular classification
Enzyme, Viral polymerase
01

Overview

RNA-directed RNA polymerase L (RSV L protein) is the large catalytic subunit of the respiratory syncytial virus (RSV) polymerase complex, essential for viral genome replication, transcription, and processing of viral mRNA. The protein (~250 kDa) comprises multiple functional domains: an RNA-dependent RNA polymerase (RdRp), a capping (PRNTase) domain, and a methyltransferase domain, which together orchestrate RNA synthesis, mRNA capping, methylation, and polyadenylation. RSV L associates with a tetrameric phosphoprotein (P) for full activity, forming a dynamic, multi-protein complex that precisely regulates initiation, elongation, and processing of RSV RNAs. Mutations in L are linked to resistance against polymerase inhibitors, making it a central focus for antiviral drug discovery against RSV infections

Other names
Large protein (L protein)RNA polymerase LRSV L polymerase
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerization (blocks viral replication/transcription) Inhibition of capping/methylation enzymatic activities Allosteric inhibition or escape (some drugs induce mutations in L to escape inhibition)

03

Biological functions

Viral RNA synthesismRNA cappingCap methylationPolyadenylation
04

Disease associations

Infection
05

Safety considerations

Resistance mutationsSubtype differencesOff-target effects
06

Interacting drugs

AZ-27

1 more in the full profile.

07

Biomarkers

Mutations in L proteinViral load (RSV RNA)

Beyond the preview

Go deeper on RNA-directed RNA polymerase L (Respiratory syncytial virus) (RSV L protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-directed RNA polymerase L (Respiratory syncytial virus) (RSV L protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call